BBCMF (Lir Life Sciences) Total Operating Expense: $1.67 Mil (TTM As of Jan. 2026)


BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences Total Operating Expense?

Lir Life Sciences BBCMF -80.00% 15 Total Operating Expense is $1.67 Mil as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

Lir Life Sciences's Total Operating Expense for the three months ended in Jan. 2026 was $1.37 Mil. Lir Life Sciences's Total Operating Expense for the trailing twelve months (TTM) ended in Jan. 2026 was $1.67 Mil.

Lir Life Sciences Total Operating Expense Related Terms

Lir Life Sciences Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Total Operating Expense Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
Total Operating Expense
0.00 0.30

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Total Operating Expense Get a 7-Day Free Trial 0.08 0.16 0.10 0.04 1.37
BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $1.67 Mil mean?
Lir Life Sciences (BBCMF) has a Total Operating Expense of $1.67 Mil as of Jan. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Lir Life Sciences and its competitors.
Is Lir Life Sciences' Total Operating Expense too high?
Lir Life Sciences' current Total Operating Expense is $1.67 Mil. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Total Operating Expense compare to VRTX and REGN?
Lir Life Sciences' Total Operating Expense of $1.67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Lir Life Sciences and its competitors. Lir Life Sciences's current Total Operating Expense is $1.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Total Operating Expense of $1.67 Mil. The current Total Operating Expense is $1.67 Mil. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Total Operating Expense is $1.67 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price